Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,770Revenue $M778Net Margin (%)22.6Z-Score18.3
Enterprise Value $M2,584EPS $2.3Operating Margin %35.3F-Score7
P/E(ttm))16.9Cash Flow Per Share $1.4Pre-tax Margin (%)35.7Higher ROA y-yY
Price/Book4.010-y EBITDA Growth Rate %0Quick Ratio3.7Cash flow > EarningsY
Price/Sales3.85-y EBITDA Growth Rate %26.5Current Ratio4.0Lower Leverage y-yY
Price/Cash Flow19.2y-y EBITDA Growth Rate %29.1ROA % (ttm)22.1Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)24.9Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M74.8ROI % (ttm)21.6Gross Margin Increase y-yN

Gurus Latest Trades with MYGN

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MYGNJohn Burbank 2014-06-30 Buy 0.01%$33.1 - $42.21
($37.18)
$ 38.062%New holding, 16676 sh.16,676
MYGNJohn Griffin 2014-06-30 Sold Out -0.38%$33.1 - $42.21
($37.18)
$ 38.062%Sold Out0
MYGNJean-Marie Eveillard 2014-06-30 Sold Out -0.03%$33.1 - $42.21
($37.18)
$ 38.062%Sold Out0
MYGNJohn Griffin 2014-03-31 Buy 0.38%$20.79 - $38.17
($30.6)
$ 38.0624%New holding, 1000000 sh.1,000,000
MYGNJean-Marie Eveillard 2014-03-31 Buy 0.03%$20.79 - $38.17
($30.6)
$ 38.0624%New holding, 284826 sh.284,826
MYGNJoel Greenblatt 2013-12-31 Add0.18%$20.79 - $30.65
($25.36)
$ 38.0650%Add 36.27%1,316,314
MYGNRonald Muhlenkamp 2013-12-31 Sold Out -2.3%$20.79 - $30.65
($25.36)
$ 38.0650%Sold Out0
MYGNJoel Greenblatt 2013-09-30 Add0.32%$24.396 - $31.8
($28.51)
$ 38.0634%Add 74.78%965,987
MYGNRonald Muhlenkamp 2013-06-30 Buy 2.7%$24.35 - $34.26
($28.98)
$ 38.0631%New holding, 481900 sh.481,900
MYGNRon Baron 2013-06-30 Sold Out -0.09%$24.35 - $34.26
($28.98)
$ 38.0631%Sold Out0
MYGNJoel Greenblatt 2013-03-31 Add0.24%$24.19 - $27.68
($25.95)
$ 38.0647%Add 62.99%489,388
MYGNRon Baron 2013-03-31 Buy 0.09%$24.19 - $27.68
($25.95)
$ 38.0647%New holding, 658653 sh.658,653
MYGNJoel Greenblatt 2012-03-31 Add0.22%$20.36 - $25.64
($21.82)
$ 38.0674%Add 40.27%363,079
MYGNJoel Greenblatt 2011-12-31 Add0.11%$18.25 - $21.76
($20.37)
$ 38.0687%Add 21.4%258,844
MYGNJoel Greenblatt 2011-09-30 Add0.1%$17.86 - $23.86
($20.44)
$ 38.0686%Add 17.12%213,215
MYGNGeorge Soros 2011-09-30 Sold Out -0.0022%$17.86 - $23.86
($20.44)
$ 38.0686%Sold Out0
MYGNJoel Greenblatt 2011-06-30 Add0.24%$19.92 - $25.53
($22.77)
$ 38.0667%Add 70.62%182,045
MYGNGeorge Soros 2011-06-30 Buy $19.92 - $25.53
($22.77)
$ 38.0667%New holding, 6800 sh.6,800
MYGNJoel Greenblatt 2011-03-31 Add0.42%$18.47 - $22.84
($19.91)
$ 38.0691%Add 182.55%106,696
MYGNGeorge Soros 2011-03-31 Sold Out $18.47 - $22.84
($19.91)
$ 38.0691%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MYGN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
MYGN John Burbank 2014-06-3016,6760.020.01New Buy
MYGN Joel Greenblatt 2014-06-301,117,3511.490.54-7.36%
MYGN John Griffin 2014-06-30000Sold Out
MYGN Jean-Marie Eveillard 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


MYGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LANCHBURY JERRY SChief Scientific Officer 2014-07-14Sell20,000$39.85-7.1view
MELDRUM PETER DPresident & C.E.O. 2014-07-14Sell24,000$39.5-6.28view
HENDERSON JOHN TDirector 2014-06-05Sell5,000$35.73.7view
Rogers Ronald S.Exec VP Corp Communications 2014-05-09Sell12,500$36.012.8view
MARSH RICHARD ME.V.P., General Counsel 2014-04-30Sell30,000$41.8-11.44view
MARSH RICHARD ME.V.P., General Counsel 2014-04-23Sell31,516$39.8-6.98view
MARSH RICHARD ME.V.P., General Counsel 2014-04-16Sell28,484$39.8-6.98view
Hart Jayne B.Executive VP Human Resources 2014-04-07Sell79,000$40.9-9.49view
LANCHBURY JERRY SChief Scientific Officer 2014-04-02Sell93,000$39.7-6.75view
Evans James SCFO 2014-04-02Sell80,000$40-7.45view

Press Releases about MYGN :

    Quarterly/Annual Reports about MYGN:

    News about MYGN:

    Articles On GuruFocus.com
    Why I Bought Myriad Genetics (MYGN) Apr 28 2014 
    Scott Black, Delphi Management Recommends Stocks Nov 19 2013 
    Surfing for Billionaire Bargains Sep 22 2013 
    Baron Funds Comments on Myriad Genetics Inc. Jun 06 2013 
    RS Investments' Value Fund First Quarter 2012 Mutual Fund Commentary Apr 17 2012 
    Chuck Royce Buys Hawkins Inc., Myriad Genetics, and Fairchild Semiconductor Jul 07 2011 
    Myriad Genetics Inc. Reports Operating Results (10-Q) May 05 2010 
    Myriad Genetics Inc. (MYGN) CFO James S Evans sells 8,400 Shares Mar 12 2010 
    Guru Stocks at 52-Week Low: Nasdaq, Dun & Bradstreet Corp, GameStop Corp, Dean Foods Company, Myriad Feb 15 2010 
    Myriad Genetics Inc. Reports Operating Results (10-Q) Feb 03 2010 

    More From Other Websites
    Myriad Genetics Posts Encouraging myPath Melanoma Data Sep 10 2014
    Myriad myPath(TM) Melanoma Test Reduced Indeterminate Cases by 76 Percent and Changed Treatment in... Sep 09 2014
    Myriad Publishes myRisk Hereditary Cancer Study in Cancer Sep 03 2014
    Myriad Genetics to Present at the Morgan Stanley Healthcare Conference Aug 28 2014
    MYRIAD GENETICS INC Financials Aug 22 2014
    MYRIAD GENETICS INC Files SEC form 10-K, Annual Report Aug 13 2014
    Myriad Genetics Dives, But Analysts Upbeat On MyRisk Aug 13 2014
    Myriad Genetics: Not as Bad as It Looks? Aug 13 2014
    Myriad Genetics' Q4 Earnings Beat Estimates, Revenues Up Y/Y Aug 13 2014
    Myriad Genetics Guidance Disappoints, Q4 Edges Views Aug 12 2014
    Myriad Genetics profit forecast misses estimates Aug 12 2014
    Myriad Genetics Inc Earnings Call scheduled for 4:30 pm ET today Aug 12 2014
    MYRIAD GENETICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 12 2014
    Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2014 Financial Results Aug 12 2014
    Q4 2014 Myriad Genetics Earnings Release - After Market Close Aug 12 2014
    Why Myriad Genetics (MYGN) Could Beat Earnings Estimates Again Aug 12 2014
    Myriad Genetics' Earnings Face 'Angelina Jolie' Comps Aug 11 2014
    Is a Surprise Coming for Myriad Genetics (MYGN) This Earnings Season? Aug 08 2014
    Myriad Genetics to Announce Financial Results for the Fiscal Fourth Quarter and Full Year 2014 on... Jul 30 2014
    Top Value Vs. Top Growth Stock Mutual Funds Jul 17 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    Antoniy
    ReplyAntoniy - 8 months ago
    hs
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK